Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
41 - 50 out of 507Page size: 10
  1. 2023
  2. Published

    Design and methodology of the PRIMETIME 1 cohort study: PRecIsion MEdicine based on kidney TIssue Molecular interrogation in diabetic nEphropathy

    Jensen, K. H., Persson, F., Hansen, Ditte, Bressendorff, I., Møller, M., Rossing, Peter, Gravesen, E., Kosjerina, V., Vistisen, D. & Borg, Rikke, 2023, In: Clinical Kidney Journal. 16, 12, p. 2482-2492 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE)

    Green, J. B., Mottl, A. K., Bakris, G., Heerspink, H. J. L., Mann, J. F. E., Mcgill, J. B., Nangaku, M., Rossing, Peter, Scott, C., Gay, A. & Agarwal, R., 2023, In: Nephrology Dialysis Transplantation. 38, 4, p. 894-903 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Differential Methylation of Telomere-Related Genes Is Associated with Kidney Disease in Individuals with Type 1 Diabetes

    Hill, C., Duffy, S., Kettyle, L. M., McGlynn, L., Sandholm, N., Salem, R. M., Thompson, A., Swan, E. J., Kilner, J., Rossing, Peter, Shiels, P. G., Lajer, M., Groop, P. H., Maxwell, A. P., McKnight, A. J. & on behalf of the GENIE Consortium, O. B. O. T. G. C., 2023, In: Genes. 14, 5, 24 p., 1029.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Discordance Between Creatinine-Based and Cystatin C–Based Estimated GFR: Interpretation According to Performance Compared to Measured GFR

    Wang, Y., Adingwupu, O. M., Shlipak, M. G., Doria, A., Estrella, M. M., Froissart, M., Gudnason, V., Grubb, A., Kalil, R., Mauer, M., Rossing, Peter, Seegmiller, J., Coresh, J., Levey, A. S. & Inker, L. A., 2023, In: Kidney Medicine. 5, 10, 13 p., 100710.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Effect of SGLT2 Inhibitors on Discontinuation of Renin–angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials

    Fletcher, R. A., Jongs, N., Chertow, G. M., McMurray, J. J. V., Arnott, C., Jardine, M. J., Mahaffey, K. W., Perkovic, V., Rockenschaub, P., Rossing, Peter, Correa-Rotter, R., Toto, R. D., Vaduganathan, M., Wheeler, D. C., Heerspink, H. J. L. & Neuen, B. L., 2023, In: Journal of the American Society of Nephrology. 34, 12, p. 1965-1975 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes

    Agarwal, R., Ruilope, L. M., Ruiz-Hurtado, G., Haller, H., Schmieder, R. E., Anker, S. D., Filippatos, G., Pitt, B., Rossing, Peter, Lambelet, M., Nowack, C., Kolkhof, P., Joseph, A. & Bakris, G. L., 2023, In: Journal of Hypertension. 41, 2, p. 295-302 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Effect of finerenone on the occurrence of vision-threatening complications in patients with non-proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR)

    Rossing, Peter, Garweg, J. G., Anker, S. D., Osonoi, T., Pitt, B., Rosas, S. E., Ruilope, L. M., Zhu, D., Brinker, M., Finis, D., Leal, S., Schmelter, T. & Bakris, G., 2023, In: Diabetes, Obesity and Metabolism. 25, 3, p. 894-898 5 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  9. Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis

    Rossing, Peter, Bain, S. C., Bosch-Traberg, H., Sokareva, E., Heerspink, H. J. L., Rasmussen, S. & Mellbin, L. G., 2023, In: Cardiovascular Diabetology. 22, 11 p., 220.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. E-pub ahead of print

    Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex

    Yu, M. K., Vart, P., Jongs, N., Correa-Rotter, R., Rossing, Peter, McMurray, J. J. V., Hou, F., Douthat, W., Khullar, D., Langkilde, A. M., Wheeler, D. C., Heerspink, H. J. L. & Chertow, G. M., 2023, (E-pub ahead of print) In: Journal of General Internal Medicine.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial

    Chertow, G. M., Correa-Rotter, R., Vart, P., Jongs, N., McMurray, J. J. V., Rossing, Peter, Langkilde, A. M., Sjöström, C. D., Toto, R. D., Wheeler, D. C., Heerspink, H. J. L. & Dapa-Ckd Trial Committees Investigators, D. T. C. I., 2023, In: Journal of the American Heart Association. 12, 9, 22 p., e028739.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...51 Next

ID: 12937790